• 1
    Burr ML, Butland BK, King S, Vaughan-Williams E. Changes in asthma prevalence: two surveys 15 years apart. Arch Dis Child 1989;64:14526.
  • 2
    Ninan TK., Russell G. Respiratory symptoms and atopy in Aberdeen schoolchildren: evidence from two surveys 25 years apart. BMJ 1992;304:8735.
  • 3
    Omran M, Russell G. Continuing increase in respiratory symptoms and atopy in Aberdeen schoolchildren BMJ 1996;312:34.
  • 4
    Warner JO. Childhood factors in the development of rhinitis and asthma. In: Is the nose a surrogate for the lungs? Proceedings of World Allergy Forum Symposium, Cancun, Mexico, International Association of Allergology and Clinical Immunology, 1997:4372.
  • 5
    Department of Health Advisory Group on the Medical Aspects of Air Pollution Episodes. First report – ozone. London : HMSO, 1991.
  • 6
    Department of Health Advisory Group on the Medical Aspects of Air Pollution Episodes. Second report – sulphur dioxide, acid aerosols and particulates. London : HMSO, 1992.
  • 7
    Department of Health Advisory Group on the Medical Aspects of Air Pollution Episodes. Third report – oxides of nitrogen. London : HMSO, 1993.
  • 8
    Department of Environment Expert Panel on Air Quality Standards. Report – particles. London : HMSO, 1995.
  • 9
    Pope CA III, Thun MJ, Namboodiri MM, et al. Particulate air pollution as a predictor of mortality in a prospective study of US adults. Am J Respir Crit Care Med 1995;151:66974.
  • 10
    Pauli G, Kopferschmitt MC, Spirlet F, Charpin D. Air pollutants and allergic sensitisation. In: ChanezP, BousquetJ, MichelFB, GodardP, editors. From genetics to quality of life. Göttingen : Hogrefe & Huber, 1996:809.
  • 11
    Ishizaki T, Koizumi K, Ikemori R, Ishiyama Y, Kushibiki E. Studies of prevalence of Japanese cedar pollinosis among residents in a densely cultivated area. Ann Allergy 1987;58:26570.
  • 12
    von Mutius E, Fritzsch C, Weiland SK., Roll G., Magnussen H. Prevalence of asthma and allergic disorders among children in united Germany. BMJ 1992;305:13959.
  • 13
    Heinrich J, Richter K, Magnussen H, Wichmann HE. Do asthma and asthma symptoms in adults already converge between East and West Germany Am J Respir Crit Care Med 1996;153(4):A856.
  • 14
    Wichmann HE. Possible explanation for the different trend of asthma and allergy in East and West Germany. Clin Exp Allergy 1996;26:6213.
  • 15
    PopeAM, PattersonR, BurgeH, editors. Indoor allergens. Washington , DC : National Academy Press, 1993:35.
  • 16
    von Mutius E, Martinez FD, Nicolai T. Skin test reactivity and coal burning [Abstract]. J Allergy Clin Immunol 1995;95:211.
  • 17
    Luczynska CM, Walker LA, Burney PGJ. Skin sensitivity in schoolchildren in two different areas of London [Abstract]. Eur Respir J 1995;8(19):350s.
  • 18
    Wallis DN, Davidson AC, Welch J, et al. Clinical and immunological characteristics of patients with thunderstorm asthma [Abstract]. Eur Respir J 1995;8:500s.
  • 19
    Thames Region Accident and Emergency Trainees Association, Davidson AC, Emberlin J., Cook AD, Venables KM. A major outbreak of asthma associated with a thunderstorm: experience of accident and emergency departments and patients' characteristics. BMJ 1996;312:6014.
  • 20
    Knox RB. Grass pollen, thunderstorms and asthma. Clin Exp Allergy 1993;23:3549.
  • 21
    Bylin G, Hedenstirna G, Linduall T, Sundin B. Ambient nitrogen dioxide concentrations increase bronchial responsiveness in subjects with mild asthma. Eur Respir J 1988;1:60612.
  • 22
    Seal E, McDonnell WF, House DE. Pulmonary function and symptom response of resting humans exposed to low concentrations of ozone for 6.8 hours [Abstract]. Am J Respir Crit Care Med 1996;153(4):A303.
  • 23
    Folinsbee LJ, Horstman DH, Kehrl HR, Harder S, Abdul-Salaam S, Ives PJ. Respiratory responses to repeated prolonged exposure to 0.12 ppm ozone. Am J Respir Crit Care Med 1994;149:98105.
  • 24
    Jörres R, Magnussen H. Airways response of asthmatics after a 30 minute exposure, at resting ventilation, to 0.25 ppm NO2, or 0.5 ppm SO2. Eur Respir J 1990;3:1327.
  • 25
    Koenig JQ, Covert DS, Hanley QS, Belle GV, Pierson WE. Prior exposure to ozone potentiates subsequent response to sulphur dioxide in adolescent asthmatic subjects. Am Rev Respir Dis 1990;141:37780.
  • 26
    Molfino NA, Wright SC, Katz I, et al. Effect of low concentrations of ozone on inhaled allergen responses in asthmatic subjects. Lancet 1991;338:199203.
  • 27
    Ball BA, Folinsbee LJ, Peden DB, Kehrl HR. Allergen bronchoprovocation of patients with mild allergic asthma after ozone exposure. J Allergy Clin Immunol 1996;98:56372.
  • 28
    Chen LL, Scannell CH, Tager I, et al. Effects of ozone on the response to inhaled antigen in allergic asthmatic subjects [Abstract]. Am J Respir Crit Care Med 1995;151:A27.
  • 29
    Jörres R, Nowak D, Magnussen H. Effect of ozone exposure on allergen responsiveness in subjects with asthma orrhinitis. Am J Respir Crit Care Med 1996;153:5664.
  • 30
    Tunnicliffe WS, Burge PS, Ayres JG. Effect of domestic concentrations of nitrogen dioxide on airway responses to inhaled allergen in asthmatic patients. Lancet 1994;344:17336.
  • 31
    Devalia JL, Rusznak C, Herdman MJ, Trigg CJ, Tarraf H, Davies RJ. Effect of nitrogen dioxide and sulphur dioxide on the airway response of mild asthmatic patients to allergen inhalation. Lancet 1994;344:166871.
  • 32
    Rusznak C, Devalia JL, Davies RJ. The airway response of asthmatic subjects to inhaled allergen after exposure to pollutants. Thorax 1996;51:11058.
  • 33
    Behrendt H, Becker WM, Friedrichs KH, Darsow U, Tomingas R. Interaction between aeroallergens and airborne particulate matter. Int Arch Allergy Immunol 1992;99:4258.
  • 34
    Thomas P, Deutinger P, Heubl G, Strube D, Przybilla B. Influence of gaseous pollutants on pollen viability (PV), germination (PG) and protein release (PR) [Abstract]. J Allergy Clin Immunol 1996;97(1):218.
  • 35
    Knox RB, Suphioglu C, Taylor P, Peng JL., Bursill LA. Asthma and air pollution: major grass pollen allergen binds to diesel exhaust particles (DECP) [Abstract]. J Allergy Clin Immunol 1996;97(1):378.
  • 36
    Wjst M, Heinrich J, Liu P, et al. Indoor factors and IgE levels in children. Allergy 1994;49:76671.
  • 37
    Osebold JW, Owens SL, Zee YC, Dotson WM, LaBarre DD. Immunological alterations in the lungs of mice following ozone exposure: changes in immunoglobulin levels and antibody containing cells. Arch Environ Health 1979;34:25865.
  • 38
    Biagini RE, Moorman WJ, Lewis TR, Bernstein IL. Ozone enhancement of platinum asthma in a primate model. Am Rev Respir Dis 1986;134:71925.
  • 39
    Miyamoto T, Takafuji S, Suzuki S, Tadakoro K, Muranaka M. Allergy and changing environments - industrial/urban pollution. In: PicklerWJ, StadlerBM, DahindenCA, et al. editors. Progress in allergy and clinical immunology. Toronto : Hogrefe & Huber, 1989:26570.
  • 40
    Berciano FA, Crespo M, Bao CG, Alvarez FV. Serum levels of total IgE in non-allergic children: influence of genetic and environmental factors. Allergy 1987;42:27683.
  • 41
    Diaz-Sanchez D, Dotson AR, Takenaka H, Saxon A. Diesel exhaust particles induce local IgE production in vivo and alter the pattern of IgE messenger RNA isoforms. J Clin Invest 1994;94:141725.
  • 42
    Diaz-Sanchez D, Saxon A. The effect of diesel exhaust particles on allergic diseases. Allergy Clin Immunol Int 1996;8(2):579.
  • 43
    Diaz-Sanchez D. The role of diesel exhaust particles and their associated polyaromatic hydrocarbons in the induction of allergic airway disease. Allergy 1997;52 Suppl 38:526.
  • 44
    Tsien A, Diaz-Sanchez D, Ma I, Saxon A. Diesel exhaust particles and phenanthrene enhance IgE production by human B cells in vitro [Abstract]. J Allergy Clin Immunol 1996;97(1):202.
  • 45
    Takenaka H, Zhang K, Diaz-Sanchez D, Tsien A, Saxon A. Enhanced human IgE production results from exposure to the aromatic hydrocarbons from diesel exhaust: direct effects on B-cell IgE production. J Allergy Clin Immunol 1995;95:10315.
  • 46
    Sato MI, Valent GU, Coimbrao CA, et al. Mutagenicity of airborne particulate organic material from urban and industrial areas of São Paulo, Brazil. Mutat Res 1995;335(3):31730.
  • 47
    Osomio-Vargas AR, Alfaro-Moreno E, Rosas I, et al. The in vitro toxicity of ambient PM10 particles from the southern, central and northern regions of Mexico City to lung fibroblasts is related to transition metal content [Abstract]. Am J Respir Crit Care Med 1996;153(4):A15.
  • 48
    Bascom R, Nacleiro RM, Fitzgerald TK, Kagey-Sobotka A, Proud D. Effect of ozone inhalation on the response to nasal challenge with antigen of allergic subjects. Am Rev Respir Dis 1990;142:594601.
  • 49
    Devlin RB, McDonnell WF, Mann R, et al. Exposure of humans to ambient levels of ozone for 6.6 hours causes cellular and biochemical changes in lung. Am J Respir Cell Mol Biol 1991;4:7281.
  • 50
    Aris RM, Christian D, Hearne PQ, Kerr K, Finkbeiner WE, Balmes JR. Ozone-induced airway inflammation in human subjects as determined by airway lavage and biopsy. Am Rev Respir Dis 1993;148:136372.
  • 51
    Basha MA, Gross KB, Gwizdala CJ, Haidar AH, Popovich J Jr. Bronchoalveolar lavage neutrophilia in asthmatic and healthy volunteers after controlled exposure to ozone and filter purified air. Chest 1994;106:175765.
  • 52
    Sandström T, Sternberg N, Eklund A, et al. Inflammatory cell response in bronchoalveolar lavage fluid after nitrogen dioxide exposure of healthy subjects: a dose-response study. Eur Respir J 1991;3:3329.
  • 53
    Helleday R, Hubermann D, Blomberg A, Sterjnberg A, Sandström T. Nitrogen dioxide exposure impairs the frequency of the mucociliary activity in healthy subjects. Eur Respir J 1995;8:16648.
  • 54
    Peden DB, Setzer RW Jr, Devlin RB. Ozone exposure has both a priming effect on allergen-induced responses and an intrinsic inflammatory action in the nasal airways of perennially allergic asthmatics. Am J Respir Crit Care Med 1995;151:133645.
  • 55
    Wang J, Devalia JL, Duddle JM, Hamilton SA, Davies RJ. The effect of exposure for six hours to nitrogen dioxide (NO2) on early phase nasal response to allergen challenge in patient with a history of seasonal allergic rhinitis. J Allergy Clin Immunol 1995;96:66976.
  • 56
    Devalia JL, Wang JH, Rusznak C, Bagnall A, Davies RJ. The effect of fluticasone propionate aqueous nasal spray on allergen-induced inflammatory changes in the nasal airways of allergic rhinitics following exposure for six hours to 400 ppb nitrogen dioxide (NO2) [Abstract], Eur Respir J 1996;9 Suppl 23:86s.
  • 57
    Rusznak C, Wang JH, Khair OA, Devalia JL, Davies RJ. Effect of fluticasone propionate (FP) on ozone (O3)-induced inflammatory cell changes, following segmental allergen challenge in mild asthmatics [Abstract]. J Allergy Clin Immunol 1996;97:(1, Pt 3)250.
  • 58
    Oberdorster G, Finkelstein J, Ferin J, et al. Ultrafine particles as a potential environmental health hazard. Studies with model particles. Chest 1996;109(3):68S9S.
  • 59
    Devalia JL, Davies RJ. Airway epithelial cells and mediators of inflammation. Respir Med 1993;87:4058.
  • 60
    Arai K, Yokota T, Watanabe S, Arai N, Miyajima A. The regulation of allergic response by cytokine receptor networks. Allergy Clin Immunol News 1992;4:11012.
  • 61
    Kips JC, Joos GF, Peleman RA, Pauwels RA. Cytokines in asthma - the latest results. Allergy Clin Immunol News 1992;4:11320.
  • 62
    Wang JH, Devalia JL, Xia C, Sapsford RJ, Davies RJ. Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am J Respir Cell Mol Biol 1996;14:2735.
  • 63
    Laberge S, Ernst P, Ghaffar O, et al. Increase in interleukin-16 (IL-16) expression in baseline asthma [Abstract], J Allergy Clin Immunol 1996;97(1):313.
  • 64
    Devalia JL, Sapsford RJ, Cundell DR, Rusznak C, Campbell AM, Davies RJ. Human bronchial epithelial cell dysfunction following exposure to nitrogen dioxide, in vitro. Eur Respir J 1993;6:130816.
  • 65
    Devalia JL, Campbell AM, Sapsford RJ, et al. Effect of nitrogen dioxide on synthesis of inflammatory cytokines expressed by human bronchial epithelial cells in vitro. Am J Respir Cell Mol Biol 1993;9:2719.
  • 66
    Rusznak C, Devalia JL, Sapsford RJ, Davies RJ. Ozoneinduced release of inflammatory mediators from human bronchial epithelial cells in vitro and the influence of nedocromil sodium. Eur Respir J 1996;9:22982305.
  • 67
    Luchtel DL, Potter-Perigo SD, Kaplan ED, Baker C, Altman LC, Wight TN. Ozone alters the expression of tenascin and decorin in differentiated primate nasal epithelial cells in culture [Abstract]. Am J Respir Crit Care Med 1996;153(4):A302.
  • 68
    Bayram H, Devalia JL, Sapsford RJ, et al. The effect of diesel exhaust particulates on cell function and release of inflammatory mediators from human bronchial epithelial cells in vitro. Am J Respir Cell Mol Biol 1998;18:(in press).
  • 69
    Rusznak C, Devalia JL, Sapsford RJ, Wood AJ, Davies RJ, Lozewicz S. Effect of cigarette smoke on house dust mite allergen (Der p l)-induced increase in human bronchial epithelial cell permeability in vitro. J Allergy Clin Immunol 1997;99(1, Pt 1):S364.
  • 70
    Mullol J, Xaubet A, Gaya A, et al. Cytokine gene expression and release from epithelial cells. A comparison study between healthy nasal mucosa and nasal polyps. Clin Exp Allergy 1995;25:60715.
  • 71
    Ohtoshi T, Tsuda T, Vancheri C, et al. Human upper airway epithelial cell-derived granulocyte-macrophage colonystimulating factor induces histamine-containing cell differentiation of human progenitor cells. Int Arch Allergy Appl Immunol 1991;95:37684.
  • 72
    Calderón MA, Devalia JL., Prior AJ, Sapsford RJ, Davies RJ. A comparison of cytokine release from epithelial cells cultured from nasal biopsy specimens of atopic patients with and without rhinitis and nonatopic subjects without rhinitis. J Allergy Clin Immunol 1997;99:6576.
  • 73
    Sousa AR, Poston RN, Lane SJ, Nakhosteen JA, Lee TH. Detection of GM-CSF in asthmatic bronchial epithelium and decrease by inhaled corticosteroids. Am Rev Respir Dis 1993;147:155761.
  • 74
    Sousa AR, Lane SJ, Nakhosteen JA, Yoshimura T, Lee TH, Poston RN. Increased expression of the monocyte chemo-attractant protein-1 in bronchial tissue from asthmatic subjects. Am J Respir Cell Mol Biol 1994;10:1427.
  • 75
    Marini M, Vittori E, Hollomberg T, Mattoli S. Expression of the potent inflammatory cytokines granulocyte/macrophage-colony stimulating factor and interleukin-6 and interleukin-8 in bronchial epithelial cells of patients with asthma. J Allergy Clin Immunol 1992;89:10019.
  • 76
    Laberge S, Ernst P, Ghaffar O, et al. Increase in interleukin-16 (IL-16) expression in baseline asthma [Abstract]. J Allergy Clin Immunol 1996;97(1, Pt 3):313.
  • 77
    Wang JH, Trigg CJ., Devalia JL, Jordan S, Davies RJ. Effect of inhaled beclomethasone dipropionate on expression of pro-inflammatory cytokines and activated cosinophils in the bronchial epithelium of mild asthmatics. J Allergy Clin Immunol 1994;94:102534.
  • 78
    Bayram H, Devalia JL, Khair OA, et al. Effect of diesel exhaust particles (DEP) on release of inflammatory mediators from bronchial epithelial cell cultures of non-atopic non-asthmatic and atopic asthmatic subjects in vitro Eur Respir J 1997;10 Suppl 25:414s.